A classical PKA inhibitor increases the oncolytic effect of M1 virus via activation of exchange protein directly activated by cAMP 1

Oncolytic virotherapy is an emerging and promising treatment modality that uses replicating viruses as selective antitumor agents. Here, we report that a classical protein kinase A (PKA) inhibitor, H89, synergizes with oncolytic virus M1 in various cancer cells through activation of Epac1 (exchange...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Li, Kai, Liang, Jiankai, Lin, Yuan, Zhang, Haipeng, Xiao, Xiao, Tan, Yaqian, Cai, Jing, Zhu, Wenbo, Xing, Fan, Hu, Jun, Yan, Guangmei
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2016
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5217030/
https://ncbi.nlm.nih.gov/pubmed/27374176
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.10305
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars